- Companies
- Ersu
Ersu Valuation Multiples
Ersu is valued at $10M as of September 2026, a 2.4x revenue multiple. In the last fiscal year, Ersu revenue was $3M and Ersu EBITDA was ($1M).
Ersu Overview
About Ersu
Ersu Meyve ve Gida Sanayi AS is engaged in manufacturing concentrate and pulp juices in Turkey. The product offerings of the company include Pear juice concentrate, Quince juice concentrate, Blackberry juice concentrate, Apple juice concentrate, Pear puree, Strawberry puree, and Tomato Paste among others.
Founded
1968
HQ
Employees
45
Website
Sectors
Financials (Last FY)
EV
$8M
Valuation Multiples
Start free trialErsu Financials
Ersu reported last fiscal year revenue of $3M and negative EBITDA of ($1M).
In the same fiscal year, Ersu generated ($83K) in gross profit, ($1M) in EBITDA losses, and had net loss of ($3M).
Ersu P&L
In the most recent fiscal year, Ersu reported revenue of $3M and EBITDA of ($1M).
Ersu is unprofitable as of last fiscal year, with gross margin of (3%), EBITDA margin of (32%), and net margin of (76%).
Financial data powered by Morningstar, Inc.
Ersu Stock Performance
Ersu has current market cap of $10M, and enterprise value of $8M.
Ersu's stock price is $0.29.
Ersu has an EPS (earnings per share) of $-0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $10M | -10.0% | - | - | - | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialErsu Valuation Multiples
Ersu trades at 2.4x EV/Revenue multiple, and (7.4x) EV/EBITDA.
Ersu Financial Valuation Multiples
As of September 23, 2026, Ersu has market cap of $10M and EV of $8M.
Ersu has a P/E ratio of (4.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ersu Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ersu Margins & Growth Rates
In the most recent fiscal year, Ersu reported gross margin of (3%), EBITDA margin of (32%), and net margin of (76%).
Ersu Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Ersu Operational KPIs
Ersu's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Ersu Competitors
Ersu competitors include Plasmapp Co, Laboratorio Farmaceutico, Civita Group, New Nordic Healthbrands, Cartier Saada, Willamette Valley, Kalve Coffee, Nuchev, M Food and Australian Dairy.
Most Ersu public comparables operate across Food & Beverages.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $6M | ($3M) | 2.9x | - | (6.3x) | - | |||
| $11M | $2M | 1.0x | 1.0x | 5.1x | 4.9x | |||
| $13M | $992K | 1.5x | - | 19.2x | - | |||
| $59M | $2M | 0.2x | - | 7.8x | - | |||
| - | - | - | - | - | - | |||
| $37M | $3M | 2.2x | - | 26.1x | - | |||
| $6M | $180K | 1.4x | - | 48.7x | - | |||
| $18M | ($5M) | 0.6x | 0.6x | (2.3x) | - | |||
This data is available for Pro users. Sign up to see all Ersu competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ersu
| When was Ersu founded? | Ersu was founded in 1968. |
| Where is Ersu headquartered? | Ersu is headquartered in Turkey. |
| How many employees does Ersu have? | As of today, Ersu has over 45 employees. |
| Is Ersu publicly listed? | Yes, Ersu is a public company listed on Borsa Istanbul. |
| What is the stock symbol of Ersu? | Ersu trades under ERSU ticker. |
| When did Ersu go public? | Ersu went public in 2000. |
| Who are competitors of Ersu? | Ersu main competitors include Plasmapp Co, Laboratorio Farmaceutico, Civita Group, New Nordic Healthbrands, Cartier Saada, Willamette Valley, Kalve Coffee, Nuchev, M Food, Australian Dairy. |
| What is the current market cap of Ersu? | Ersu's current market cap is $10M. |
| What is the current revenue of Ersu? | Ersu's last fiscal year revenue is $3M. |
| What is the current EV/Revenue multiple of Ersu? | Current revenue multiple of Ersu is 2.4x. |
| Is Ersu profitable? | No, Ersu is not profitable. |
| How many companies Ersu has acquired to date? | Ersu hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Ersu has invested to date? | Ersu hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ersu
Lists including Ersu
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




